Robeco Institutional Asset Management BV Cuts Holdings in CVS Health Corporation (CVS)

Janney Montgomery Scott Lowered By $1.35 Million Its Cvs Health (CVS) Stake; WEED (BUDZ) Shorts Lowered By ...

Janney Montgomery Scott Lowered By $1.35 Million Its Cvs Health (CVS) Stake; WEED (BUDZ) Shorts Lowered By ...

Front Barnett Assoc Limited Company holds 0.72% in CVS Health Corp (NYSE:CVS) or 49,317 shares. They now have $79.00 price target on the pharmacy operator's stock, up from their prior price target of $69.02. It also reduced its holding in Adobe Sys Inc (NASDAQ:ADBE) by 122,300 shares in the quarter, leaving it with 754,853 shares, and cut its stake in Apple Inc (NASDAQ:AAPL). Royal Bank Of Canada assumed coverage on shares of CVS Health Corporation in a report on Tuesday, September 19th. Finally, Sentry Investments Corp. increased its holdings in CVS Health Corporation by 1.0% during the 2nd quarter. Ontario Teachers Pension Plan Board holds 0.91% of its portfolio in CVS Health Corp (NYSE:CVS) for 937,658 shares. Oppenheimer maintained the shares of CVS in report on Monday, November 2 with "Outperform" rating. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the company's stock. Needham & Company LLC reaffirmed a "hold" rating on shares of CVS Health Corporation in a report on Sunday, September 10th. Estabrook Capital has invested 0% in CVS Health Corp (NYSE:CVS). (CARA). The consensus rating is 1.9, indicating analysts in general look favorably on the company's future prospects. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05. The firm has a market cap of $71,912.30, a price-to-earnings ratio of 12.43, a price-to-earnings-growth ratio of 1.22 and a beta of 0.86. Northstar Incorporated owns 1.26% invested in CVS Health Corp (NYSE:CVS) for 25,487 shares.

CVS Health Corporation (NYSE:CVS) reported its EPS in the last quarter as $1.5/Share beating the analyst estimate of $1.49/Share by a difference of $0.01. The average estimate of Wall Street analysts had projected 1.49. The business had revenue of $46.18 billion during the quarter, compared to analysts' expectations of $46.17 billion.

The forward P/E of CVS Health Corporation is at 11.18 signifying the uses of estimated net earnings over the next 12 months. The company has market cap of $3.34 billion.

21 analysts on average are expecting CVS Health Corporation to report earnings of $1.9 per share for the current quarter. If you are viewing this report on another site, it was stolen and republished in violation of US & global copyright & trademark law. The correct version of this piece can be accessed at https://www.truebluetribune.com/2017/11/14/robeco-institutional-asset-management-b-v-has-22-59-million-position-in-cvs-health-corporation-cvs.html.

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 3rd.

Investors sentiment decreased to 0.92 in 2017 Q2.

According to the Recommendation Trends of the stock polled by Finviz, the company has a consensus recommendation of 2.2 out of the scale from 1 to 5 where 1 stands for Buy and 5 means Sell. On October 29 analysts at Cowen and Company updated guidance on CVS stating a rating of "Buy" and establishing a price target of $86.00. CVS Health Corporation's payout ratio is now 41.32%. The consensus rating is 2.2, suggesting the market has given up on the stock. Denton David M sold $18.44M worth of stock or 230,510 shares. Thornburg Investment Management Inc accumulated 3.22M shares.

Since June 12, 2017, it had 0 buys, and 1 insider sale for $18.44 million activity.

In other news, EVP Thomas M. Moriarty sold 90,267 shares of the stock in a transaction that occurred on Monday, September 11th. Following the completion of the transaction, the executive vice president now directly owns 70,102 shares of the company's stock, valued at approximately $5,580,820.22. The disclosure for this sale can be found here. The Farmers & Merchants Investments Inc holds 194,542 shares with $15.65 million value, up from 174,595 last quarter. The number of shares now owned by investors are 31.7 mln. Keel Point LLC boosted its stake in CVS Health Corporation by 0.7% in the 1st quarter. Cohen & Steers Inc. now owns 191,794 shares of the pharmacy operator's stock worth $15,597,000 after purchasing an additional 33,672 shares during the last quarter.

Janney Montgomery Scott Llc decreased Cvs Health Corp (CVS) stake by 8% reported in 2017Q2 SEC filing. Elefante Mark B boosted its stake in CVS Health Corporation by 0.7% in the 2nd quarter. Traynor Capital Management Inc. now owns 3,676 shares of the pharmacy operator's stock worth $290,000 after purchasing an additional 48 shares during the period. Finally, Nadler Financial Group Inc. purchased a new position in shares of CVS Health Corporation during the second quarter worth approximately $202,000. Mycio Wealth Partners LLC now owns 3,616 shares of the pharmacy operator's stock valued at $346,000 after buying an additional 480 shares during the period.

TRADEMARK VIOLATION NOTICE: "Canandaigua National Bank & Trust Co".

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The return on assets ratio shows how well management is employing the company's total assets to make a profit. LTD. now owns 67,353 shares of the pharmacy operator's stock valued at $6,448,000 after buying an additional 581 shares during the period. Institutional investors own 82.04% of the company's stock.

Noticias recomendada